Patil GB, Hallikeri KS, Balappanavar AY, Hongal SG, Sanjaya PR, Sagari SG. Cyclin B1 overexpression in conventional oral squamous cell carcinoma and verrucous carcinoma- A correlation with clinicopathological features. Med Oral Patol Oral Cir Bucal. 2013 July 1;18 (4):e585-90.  

 

 

doi:10.4317/medoral.18220

http://dx.doi.org/doi:10.4317/medoral.18220

 

 

 

1. Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y, et al. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med. 2002;13:51-61.
http://dx.doi.org/10.1177/154411130201300106
PMid:12097237

 

2. Saito T, Nakajima T, Mogi K. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas. J Oral Pathol Med. 1999;28:226-32.
http://dx.doi.org/10.1111/j.1600-0714.1999.tb02029.x
PMid:10226946

 

3. Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res. 2002;8:817-22.
PMid:11895914

 

4. Li JM, Brooks G. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?. Eur Heart J. 1999;20:406-20.
http://dx.doi.org/10.1053/euhj.1998.1308

 

5. van Leuken R, Clijsters L, Wolthuis R. To cell cycle, swing the APC/C. Biochim Biophys Acta. 2008;1786:49-59. 6. Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:67-76.

 

7. Kushner J, Bradley G, Young B, Jordan RC. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J Oral Pathol Med. 1999;28:77-81.
http://dx.doi.org/10.1111/j.1600-0714.1999.tb02000.x
PMid:9950254

 

8. Pereira MC, Oliveira DT, Landman G, Kowalski LP. Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc. 2007;73:339-44.
PMid:17484800

 

9. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W, et al. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer. 2002;94:2874-81.
http://dx.doi.org/10.1002/cncr.10542
PMid:12115375

 

10. Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, et al. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis. 2008;29:307-15.
http://dx.doi.org/10.1093/carcin/bgm269
PMid:18048386

 

11. Hoffmann TK, Trellakis S, Okulicz K, Schuler P, Greve J, Arnolds J, et al. Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Anticancer Res. 2011;31:3151-7.
PMid:21965721

 

12. Geddert H, Heep HJ, Gabbert HE, Sarbia M. Expression of cyclin B1 in the metaplasia-dysplasia-carcinoma sequence of Barrett esophagus. Cancer. 2002;94:212-8.
http://dx.doi.org/10.1002/cncr.10152
PMid:11815979

 

13. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, et al. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin Cancer Res. 2009;15:3654-62.
http://dx.doi.org/10.1158/1078-0432.CCR-08-3293
PMid:19470724 PMCid:2887710

 

14. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin Cancer Res. 2001;7:2458-62.
PMid:11489826

 

15. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, et al. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res. 2002;62:6414-7.
PMid:12438226

 

16. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol. 2004;15:252-6.
http://dx.doi.org/10.1093/annonc/mdh073
PMid:14760118

 

17. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 2000;60:4000-4.
PMid:10945597

 

18. Grabsch H, Lickvers K, Hansen O, Takeno S, Willers R, Stock W, et al. Prognostic value of cyclin B1 protein expression in colorectal cancer. Am J Clin Pathol. 2004;122:511-6.
http://dx.doi.org/10.1309/54H4Q88A1UBBWPTE
PMid:15487447

 

19. Lao-Sirieix P, Brais R, Lovat L, Coleman N, Fitzgerald RC. Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis. Neoplasia. 2004;6:751-60.
http://dx.doi.org/10.1593/neo.04280
PMid:15720801 PMCid:1531679

 

20. Lawoyin JO, Lawoyin DO, Aderinokun G. Intra-oral squamous cell carcinoma in Ibadan: a review of 90 cases. Afr J Med Med Sci. 1997;26:187-8.
PMid:10456168

 

21. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128:268-74.
http://dx.doi.org/10.1001/archotol.128.3.268

 

22. de Spíndula-Filho JV, da Cruz AD, Oton-Leite AF, Batista AC, Leles CR, de Cássia Gonçalves Alencar R, et al. Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV). Tumour Biol. 2011;32:409-16.
http://dx.doi.org/10.1007/s13277-010-0135-4
PMid:21136231

 

23. Watanabe S, Watanabe R, Oton-Leite AF, Alencar Rde C, Oliveira JC, Leles CR, et al. Analysis of cell proliferation and pattern of invasion in oral squamous cell carcinoma. J Oral Sci. 2010;52:417-24.
http://dx.doi.org/10.2334/josnusd.52.417
PMid:20881335

 

24. Yoshitome S, Furuno N, Hashimoto E, Sagata N. The C-terminal seven amino acids in the cytoplasmic retention signal region of cyclin B2 are required for normal bipolar spindle formation in Xenopus oocytes and embryos. Mol Cancer Res. 2003;1:589-97.
PMid:12805406